Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):

80054498

Market status:

Marketed

Licence Status:

Active

Brand name(s):

M Sennosides ;
M-Sennosides 8.6mg

Licence holder:

Mantra Pharma Inc.

Dosage Form:

Tablet

Recommended route of administration:

Oral

Recommended use or purpose:

Soulagement de la constipation occasionnelle

Risk Information:

Cautions and Warnings 

Réduire la dose ou cesser l'utilisation si vous éprouvez de la douleur abdominale, des crampes, des spasmes et/ou de la diarrhée. Consulter un praticien de soins de santé avant d'en faire l'usage si vous prenez des médicaments pour le coeur tels que des glycosides cardiaques ou des anti-arythmisants, des diurétiques thiazidiques, des corticostéroïdes, de la racine de réglisse, tout autre médicament ou produit de santé pouvant aggraver le déséquilibre des niveaux d'électrolytes; si vous souffrez de troubles rénaux, d'un fécalome ou de symptôme tels que des douleurs abdominales, des nausées, des vomissements ou de la fièvre; si les symptômes persistent ou s'aggravent.

Contra-Indications 

Ne pas utiliser si vous êtes enceinte ou si vous allaitez. Ne pas utiliser si vous souffrez de constrictions anormales du tractus gastro-intestinal, d'une occlusion intestinale existante ou potentielles, d'un intestin paresseux, d'une appendicite, d'une maladie inflammatoire du côlon telle que la maladie de Crohn ou la colite ulcéreuse, d'une douleur abdominale d'origine inconnue, de saignements rectaux non diagnostiqués, de déshydratation sévère avec pertes en eau et en électrolytes.

Known Adverse Reactions 

Une hypersensibilité peut se manifester. Si tel est le cas, cesser l'utilisation.

List of medicinal ingredients:

Medicinal ingredients	Quantity (Qty)	Extract	Potency
Sennoside A&B	8.6 mg

List of non-medicinal ingredients:

• Cellulose - microcrystalline
• Colloidal silicon dioxide
• Corn starch
• Croscarmellose Sodium
• FD & C blue no 2 aluminium lake
• FD&C Red No. 40 Aluminum Lake
• FD&C Yellow No. 6 Aluminum Lake
• Magnesium Stearate
• Poly(alcool vinylique)
• Polyethylene Glycol
• Sodium Lauryl Sulfate
• Talc
• Titanium dioxide

Date of licensing:

2014-10-02

Revised date of licence:

2023-09-06